-+ 0.00%
-+ 0.00%
-+ 0.00%
KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro
Share
Listen to the news
KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro
  • KKR-managed funds, Hildred and EQT Life Sciences are investing new capital in Onvaro to support its growth.
  • Formed through the combination of Sapphiros and binx health, Onvaro develops diagnostics for health care and consumer settings.
  • The investment will support commercial expansion and development of decentralized testing products.
  • Onvaro's commercial portfolio centers on the binx io molecular point-of-care platform, with more than 1,000 installed instruments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KKR & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104492716) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending